Charles Y. Lin

机构：Baylor Genetics · ORCID：0000-0002-9155-090X

发表论文 287 篇 · 总被引 17767 次 · h-index 46

代表论文

• Integrative proteogenomics and forward genetics reveals a novel mitotic vulnerability in triple-negative breast cancer. (2026 · UNC Libraries)
• Antitumor Activity of CDK2/9 Inhibitor Fadraciclib in an In Vivo Model of Temozolomide-Refractory Neuroblastoma (2026 · Molecular Cancer Therapeutics)
• Figure S5 from MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer (2026)
• Table S4 from MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer (2026)
• Figure S1 from MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer (2026)
• Figure S2 from MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer (2026)